BIOSENS is a Brazilian deeptech company specialized in life sciences. Our work encompasses research, development, production, and commercialization of point-of-care testing (POCT). Our biosensor-based technology represents a new frontier with the potential to transform laboratory diagnostics and healthcare. Biosensors are analytical devices that convert biological interactions and chemical reactions into measurable data. We develop reactive strips, each embedded with a biosensor, designed for specific analyses. A widely recognized example of this technology is the glucometer, used for monitoring glucose in diabetic patients, illustrating one of the practical applications of our technology.
Our goal is to decentralize laboratory diagnostic exams with accessible solutions that positively impact health professionals, researchers, and improves the patient journey. BIOSENS combines transdisciplinary knowledge and innovation, with proprietary technology, integrating areas such as cellular biology, genetics, artificial intelligence, advanced materials, CRISPR, bionanotechnology, the Internet of Things (IoT), microfabrication, and MEMS. This integration places BIOSENS at the technological forefront, in Brazil and worldwide, merging science and technology to revolutionize healthcare, transform patient experiences, improve quality of life, and contribute to a better world.